Vascular Embolization Plugs and Coils Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.
Vascular Embolization Plugs and Coils are used for occlusion of blood flow to abnormal areas of tissue by non-surgical methods. Embolization, being a minimally invasive technique, is considered first-line therapy for the treatment of peripheral aneurysm, peripheral AVM, type II endoleak and gastrointestinal bleeding cases. The majority of the vascular embolization coils are platinum along with fibers attached made of various materials. These are used to obstruct the blood flow in the peripheral vasculature whereas vascular embolization plugs are expandable nitinol mesh vascular occlusion devices used to obstruct the blood flow in the peripheral vasculature.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Companies covered: Terumo Corp, Penumbra Inc, Medtronic Plc, Boston Scientific Corp, Cook Group Inc, Abbott Laboratories, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Vascular Embolization Plugs and Coils are used for occlusion of blood flow to abnormal areas of tissue by non-surgical methods. Embolization, being a minimally invasive technique, is considered first-line therapy for the treatment of peripheral aneurysm, peripheral AVM, type II endoleak and gastrointestinal bleeding cases. The majority of the vascular embolization coils are platinum along with fibers attached made of various materials. These are used to obstruct the blood flow in the peripheral vasculature whereas vascular embolization plugs are expandable nitinol mesh vascular occlusion devices used to obstruct the blood flow in the peripheral vasculature.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are :
Currently marketed Vascular Embolization Plugs and Coils and evolving competitive landscape :
- Insightful review of the key industry trends.
- Annualized total Vascular Embolization Plugs and Coils market revenue by segment and market outlooks from 2015-2033.
- Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights :
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition the analyst analysts provide unique country specific insights on the market.
- SWOT analysis for Vascular Embolization Plugs and Coils market.
- Competitive dynamics insights and trends provided for Vascular Embolization Plugs and Coils market.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Companies covered: Terumo Corp, Penumbra Inc, Medtronic Plc, Boston Scientific Corp, Cook Group Inc, Abbott Laboratories, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for :- CMO executives who must have deep understanding of the Vascular Embolization Plugs and Coils marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to :
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Vascular Embolization Plugs and Coils market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Vascular Embolization Plugs and Coils market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Vascular Embolization Plugs and Coils market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Terumo Corp Boston Scientific Corp
- Penumbra Inc
- Medtronic Plc
- Cook Group Inc
- Abbott Laboratories